News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
180 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
Arrowhead Pharmaceuticals Reports Fiscal 2017 Year End Results
The company is hosting a conference call at 4:30 p.m. EST to discuss results.
December 12, 2017
·
5 min read
BioForest
Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH
During ASH, Juno also announced that JCAR017 had received the United States Adopted Name (USAN) lisocabtagene maraleucel (liso-cel).
December 12, 2017
·
12 min read
Policy
FDA Delays Action Date for Pfizer’s Xeljanz sNDA App by Three Months
The FDA has provided an anticipated PDUFA date in June 2018.
December 12, 2017
·
14 min read
Virtual Incision Bags $18M for Miniaturized Surgical Robots
The cash will support the company’s 510(k) premarket notification submission to the FDA for its next-generation miniaturized robotically assisted surgical device.
December 12, 2017
·
4 min read
ESSA Pharma Announces Overnight Marketed Offering
The Offering will be conducted in each of the provinces of British Columbia, Alberta and Ontario by way of a prospectus supplement to ESSA’s base shelf prospectus dated December 22, 2015 and elsewhere on a private placement basis.
December 12, 2017
·
4 min read
Paradigm Diagnostics Announces Fusion Panel Addition to PCDx
All PCDx tests ordered for patients with lung cancer now also include 17 fusions, as well as EGFR and MET skipping events.
December 12, 2017
·
2 min read
Deals
NuVasive to Acquire SafePassage for Undisclosed Sum
With the addition of SafePassage, NCS solidifies its leadership position as the largest provider of outsourced IONM services.
December 12, 2017
·
5 min read
Business
IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement
Under the terms of this seven-year agreement, Pierre Fabre Pharmaceuticals will migrate all of its current CRM users to OCE, which Pierre Fabre Pharmaceuticals selected because of its strong “platform of platforms” foundation and open architecture.
December 12, 2017
·
5 min read
Business
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration With Major Cancer Center in HER2-Mutated Cancer
Daiichi Sankyo and Puma Biotechnology will co-sponsor the research.
December 12, 2017
·
12 min read
Helix BioPharma Corp. Announces Voting Results From Annual and Special Meeting of Shareholders
Helix BioPharma announced today the results of matters voted on at its annual and special meeting of shareholders held on December 12, 2017
December 12, 2017
·
4 min read
Previous
17 of 18
Next